Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04421963
Title Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib (ROSY-O)
Acronym ROSY-O
Recruitment Enrolling by invitation
Gender female
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.